scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00535-012-0569-0 |
P698 | PubMed publication ID | 22426637 |
P50 | author | Kazuhiko Koike | Q21699620 |
Ryosuke Tateishi | Q37838027 | ||
Shinya Matsuda | Q40486408 | ||
Hideo Yasunaga | Q40971030 | ||
P2093 | author name string | Masaya Sato | |
Haruhiko Yoshida | |||
Hiromasa Horiguchi | |||
P2860 | cites work | Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world | Q29614969 |
Management of hepatocellular carcinoma | Q29616230 | ||
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
Cancer statistics, 2005 | Q29617572 | ||
Impact of hospital volume on postoperative complications and in-hospital mortality after renal surgery: data from the Japanese Diagnosis Procedure Combination Database | Q33572466 | ||
Current treatment for colorectal cancer metastatic to the liver | Q33754893 | ||
Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database. | Q33775389 | ||
Multidisciplinary management of metastatic colorectal cancer | Q33839174 | ||
Resection of hepatocellular carcinoma: a European experience on 328 cases. | Q33958480 | ||
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan | Q34091171 | ||
Surgeon volume and operative mortality in the United States. | Q34279907 | ||
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value | Q34290128 | ||
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 Years | Q79278933 | ||
Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk | Q80141796 | ||
Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases | Q80213417 | ||
Liver resective surgery: a multivariate analysis of postoperative outcome and complication | Q80286919 | ||
Adverse effects of radiofrequency ablation of liver tumours in the Netherlands | Q81924482 | ||
Impact of hospital case volume on the quality of laparoscopic colectomy in Japan | Q84187746 | ||
Perioperative risk assessment for hepatocellular carcinoma by using the MELD score | Q84367911 | ||
Treatment of liver metastases from colorectal cancer: what is the best approach today? | Q34351014 | ||
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases | Q34390771 | ||
Impact of hospital volume on operative mortality for major cancer surgery | Q34482407 | ||
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection | Q34503100 | ||
An analysis of 412 cases of hepatocellular carcinoma at a Western center | Q34503813 | ||
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation | Q34505935 | ||
Trends in long-term survival following liver resection for hepatic colorectal metastases | Q34523502 | ||
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 | ||
Treatment of liver metastases, an update on the possibilities and results | Q34616010 | ||
Early hepatocellular carcinoma as an entity with a high rate of surgical cure | Q34754443 | ||
Results of resections for hepatocellular carcinoma in a new hepatobiliary unit | Q35048197 | ||
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome | Q35648684 | ||
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan | Q40196680 | ||
Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center | Q40518448 | ||
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis | Q42633082 | ||
The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection. | Q43709279 | ||
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. | Q44135004 | ||
Hospital volume and surgical mortality in the United States. | Q44464097 | ||
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). | Q45023757 | ||
Adverse events during radiofrequency treatment of 582 hepatic tumors. | Q45078722 | ||
Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis. | Q45982152 | ||
Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications | Q46347660 | ||
Radiofrequency ablation of unresectable hepatic malignancies: lessons learned | Q46624740 | ||
Measles-related hospitalizations and complications in Japan, 2007-2008. | Q47841319 | ||
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases | Q49186620 | ||
Volume and process of care in high-risk cancer surgery. | Q53256716 | ||
Chemoembolization in patients at high risk: results and complications. | Q54064112 | ||
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver | Q57001643 | ||
Severe Complications of Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: An Analysis of 3,891 Ablations in 2,614 Patients | Q57763662 | ||
Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer | Q71380388 | ||
Influence of hospital procedure volume on outcomes following surgery for colon cancer | Q73310903 | ||
Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases | Q73876943 | ||
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients | Q77983517 | ||
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade | Q78341860 | ||
Indications and results of resection for hepatocellular carcinoma | Q78513898 | ||
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study | Q78873230 | ||
P433 | issue | 10 | |
P921 | main subject | hepatectomy | Q1514021 |
patient | Q181600 | ||
hepatocellular carcinoma | Q1148337 | ||
P304 | page(s) | 1125-1133 | |
P577 | publication date | 2012-03-17 | |
P1433 | published in | Journal of Gastroenterology | Q15764399 |
P1476 | title | Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients | |
P478 | volume | 47 |
Q91795303 | Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy |
Q41962614 | Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update |
Q89302633 | Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma |
Q40706736 | Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan |
Q38723572 | Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection |
Q44379007 | Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery |
Q92534091 | Comparison of Microwave Ablation and Transarterial Chemoembolization for Single-Nodule Hepatocellular Carcinoma Smaller Than 5cm: A Propensity Score Matching Analysis |
Q41496862 | Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching |
Q89769440 | Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients |
Q51495586 | Cost-Effective Surgical Management of Liver Disease Amidst a Financial Crisis. |
Q33650840 | Defining incidence and risk factors of venous thromboemolism after hepatectomy. |
Q93128876 | Effective prediction of postoperative complications for patients after open hepatectomy: a simplified scoring system based on perioperative parameters |
Q36378778 | Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping |
Q64078084 | F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches |
Q34513574 | Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma. |
Q36336198 | Function and clinical potential of microRNAs in hepatocellular carcinoma. |
Q26738274 | Hepatocellular carcinoma in elderly patients: challenges and solutions |
Q46624378 | High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy. |
Q38507050 | Imaging of the postoperative liver: review of normal appearances and common complications |
Q37693431 | Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA. |
Q40162339 | Incidence and Risk Factors for Postoperative Delirium in Patients After Hepatectomy |
Q36709493 | Laparoscopic repair of diaphragm perforation with heart patch after microwave ablation |
Q37735607 | Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma. |
Q87664325 | Management of hepatocellular carcinoma |
Q26827161 | Management of hepatocellular carcinoma in the elderly |
Q26822016 | Management of post-hepatectomy complications |
Q36502706 | Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma |
Q38925394 | Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: a nationwide survey |
Q36698026 | Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan |
Q89570833 | Percutaneous treatment of IVC obstruction due to post-resection hepatic torsion associated with IVC thrombosis |
Q44749754 | Predictors of intermediate-term survival with destination locoregional therapy of hepatocellular cancer in patients either ineligible or unwilling for liver transplantation |
Q33818674 | Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study |
Q52654017 | Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer. |
Q51690868 | Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. |
Q41528463 | Randomized clinical trial of peritoneal lavage for preventing surgical site infection in elective liver surgery. |
Q33816324 | Risk factors for pulmonary complications after hepatic resection: role of intraoperative hemodynamic instability and hepatic ischemia |
Q89413813 | Risk factors of postoperative ascites on hepatic resection for hepatocellular carcinoma |
Q50478924 | Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy. |
Q39314901 | Systematic review of transarterial embolization for hepatocellular adenomas. |
Q36314348 | Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma. |
Q40808925 | The ADOPT-LC score: a novel predictive index of in-hospital mortality of cirrhotic patients following surgical procedures, based on a national survey |
Q89262908 | The Outcome of Complex Hepato-Pancreato-Biliary Surgery for Elderly Patients: A Propensity Score Matching Analysis |
Q37652110 | Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer |
Q37249500 | Treatment for hepatocellular carcinoma in elderly patients: a literature review |
Q39117225 | Using Dynamic 99mT c-GSA SPECT/CT fusion images for hepatectomy planning and postoperative liver failure prediction |
Q35457125 | Verification of inferior right hepatic vein-conserving segments 7 to 8 resection of the liver |
Search more.